Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Millendo Therapeutics Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
5 August 2026
Millendo Therapeutics Inc. BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.
Latest Hotspot
10 min read
Ameloblastoma Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Ameloblastoma indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Odontogenic keratocyst Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Odontogenic keratocyst strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
8 min read
Milestone Pharmaceuticals Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
5 August 2026
Milestone Pharmaceuticals Inc. BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.
Latest Hotspot
10 min read
Fibrous dysplasia of the jaw Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Fibrous dysplasia of the jaw strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Central giant cell granuloma Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Central giant cell granuloma strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
8 min read
Microvascular Therapeutics, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
5 August 2026
Microvascular Therapeutics, Inc. BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.
Latest Hotspot
10 min read
Bisphosphonate-related osteonecrosis of the jaw Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Bisphosphonate-related osteonecrosis of the jaw strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Medication-related osteonecrosis of the jaw Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Medication-related osteonecrosis of the jaw strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Chronic periodontitis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Chronic periodontitis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Peri-implantitis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Peri-implantitis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Aggressive periodontitis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Aggressive periodontitis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.